https://www.selleckchem.com/pr....oducts/cct251545.htm
The percentage of citations with at least 1 CPG author relative to total citations was 3.4% in Japan and 33.6% in the US. In sum, 71.4% and 88.8% of recommendations for PsA in the JDA and ACR were supported by low or very low quality of evidence. More rigorous cross-checking of information disclosed by pharmaceutical companies and self-reported by physicians and more stringent and transparent COI policies are necessary. More rigorous cross-checking of information disclosed by pharmaceutical companies and self-reported by physicians an
Like
Comment
Share
